nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—PTGS1—esophageal cancer	0.72	1	CbGaD
Zopiclone—Eszopiclone—PTGS1—esophageal cancer	0.00587	1	CrCbGaD
Zopiclone—Furuncle—Methotrexate—esophageal cancer	0.0013	0.0089	CcSEcCtD
Zopiclone—Cellulitis—Cisplatin—esophageal cancer	0.00127	0.00874	CcSEcCtD
Zopiclone—Neuralgia—Capecitabine—esophageal cancer	0.00123	0.00844	CcSEcCtD
Zopiclone—Nuchal rigidity—Methotrexate—esophageal cancer	0.00122	0.00841	CcSEcCtD
Zopiclone—Hepatomegaly—Capecitabine—esophageal cancer	0.00121	0.00828	CcSEcCtD
Zopiclone—Pain—Carboplatin—esophageal cancer	0.0012	0.00827	CcSEcCtD
Zopiclone—Metrorrhagia—Capecitabine—esophageal cancer	0.00119	0.0082	CcSEcCtD
Zopiclone—Laryngitis—Capecitabine—esophageal cancer	0.00118	0.00813	CcSEcCtD
Zopiclone—Tongue disorder—Capecitabine—esophageal cancer	0.00117	0.00806	CcSEcCtD
Zopiclone—Hiccups—Cisplatin—esophageal cancer	0.00116	0.00795	CcSEcCtD
Zopiclone—Hepatocellular injury—Cisplatin—esophageal cancer	0.00116	0.00795	CcSEcCtD
Zopiclone—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00115	0.00792	CcSEcCtD
Zopiclone—Herpes zoster—Capecitabine—esophageal cancer	0.00113	0.00778	CcSEcCtD
Zopiclone—Body temperature increased—Carboplatin—esophageal cancer	0.00111	0.00764	CcSEcCtD
Zopiclone—Otitis media—Capecitabine—esophageal cancer	0.0011	0.00753	CcSEcCtD
Zopiclone—Memory impairment—Capecitabine—esophageal cancer	0.00109	0.00747	CcSEcCtD
Zopiclone—Hyperaesthesia—Capecitabine—esophageal cancer	0.00109	0.00747	CcSEcCtD
Zopiclone—Neuropathy—Cisplatin—esophageal cancer	0.00109	0.00746	CcSEcCtD
Zopiclone—Tingling sensation—Capecitabine—esophageal cancer	0.00106	0.00729	CcSEcCtD
Zopiclone—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.000951	0.00653	CcSEcCtD
Zopiclone—Skin discolouration—Capecitabine—esophageal cancer	0.000945	0.00649	CcSEcCtD
Zopiclone—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000945	0.00649	CcSEcCtD
Zopiclone—Cellulitis—Capecitabine—esophageal cancer	0.000938	0.00644	CcSEcCtD
Zopiclone—Amnesia—Cisplatin—esophageal cancer	0.000894	0.00614	CcSEcCtD
Zopiclone—Gait disturbance—Capecitabine—esophageal cancer	0.000874	0.006	CcSEcCtD
Zopiclone—Coordination abnormal—Capecitabine—esophageal cancer	0.000869	0.00597	CcSEcCtD
Zopiclone—Hiccups—Capecitabine—esophageal cancer	0.000853	0.00586	CcSEcCtD
Zopiclone—Stupor—Methotrexate—esophageal cancer	0.000851	0.00584	CcSEcCtD
Zopiclone—Herpes zoster—Methotrexate—esophageal cancer	0.000844	0.00579	CcSEcCtD
Zopiclone—Melaena—Capecitabine—esophageal cancer	0.000834	0.00572	CcSEcCtD
Zopiclone—Urinary incontinence—Capecitabine—esophageal cancer	0.000824	0.00566	CcSEcCtD
Zopiclone—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000824	0.00566	CcSEcCtD
Zopiclone—Colitis—Capecitabine—esophageal cancer	0.000819	0.00563	CcSEcCtD
Zopiclone—Face oedema—Cisplatin—esophageal cancer	0.000811	0.00557	CcSEcCtD
Zopiclone—Irritability—Cisplatin—esophageal cancer	0.000802	0.00551	CcSEcCtD
Zopiclone—Neuropathy—Capecitabine—esophageal cancer	0.000801	0.0055	CcSEcCtD
Zopiclone—Dry eye—Capecitabine—esophageal cancer	0.000788	0.00541	CcSEcCtD
Zopiclone—Dehydration—Cisplatin—esophageal cancer	0.000782	0.00537	CcSEcCtD
Zopiclone—Mouth ulceration—Capecitabine—esophageal cancer	0.000772	0.0053	CcSEcCtD
Zopiclone—Hypokalaemia—Cisplatin—esophageal cancer	0.000765	0.00525	CcSEcCtD
Zopiclone—Cramp muscle—Cisplatin—esophageal cancer	0.000757	0.0052	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000757	0.0052	CcSEcCtD
Zopiclone—Mental disability—Capecitabine—esophageal cancer	0.000741	0.00509	CcSEcCtD
Zopiclone—Speech disorder—Methotrexate—esophageal cancer	0.000739	0.00507	CcSEcCtD
Zopiclone—Ear pain—Capecitabine—esophageal cancer	0.000726	0.00499	CcSEcCtD
Zopiclone—Thrombophlebitis—Capecitabine—esophageal cancer	0.000716	0.00491	CcSEcCtD
Zopiclone—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.000708	0.00486	CcSEcCtD
Zopiclone—Photosensitivity—Capecitabine—esophageal cancer	0.000705	0.00484	CcSEcCtD
Zopiclone—Skin discolouration—Methotrexate—esophageal cancer	0.000703	0.00483	CcSEcCtD
Zopiclone—Swelling—Capecitabine—esophageal cancer	0.000702	0.00482	CcSEcCtD
Zopiclone—Oliguria—Methotrexate—esophageal cancer	0.000689	0.00473	CcSEcCtD
Zopiclone—Libido decreased—Capecitabine—esophageal cancer	0.000668	0.00459	CcSEcCtD
Zopiclone—Increased appetite—Capecitabine—esophageal cancer	0.000659	0.00453	CcSEcCtD
Zopiclone—Amnesia—Capecitabine—esophageal cancer	0.000659	0.00453	CcSEcCtD
Zopiclone—Thirst—Capecitabine—esophageal cancer	0.000651	0.00447	CcSEcCtD
Zopiclone—Dermatitis bullous—Capecitabine—esophageal cancer	0.000648	0.00445	CcSEcCtD
Zopiclone—Arthritis—Capecitabine—esophageal cancer	0.000637	0.00438	CcSEcCtD
Zopiclone—Vaginal inflammation—Methotrexate—esophageal cancer	0.000635	0.00436	CcSEcCtD
Zopiclone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000635	0.00436	CcSEcCtD
Zopiclone—Stomatitis—Cisplatin—esophageal cancer	0.000631	0.00434	CcSEcCtD
Zopiclone—Conjunctivitis—Cisplatin—esophageal cancer	0.00063	0.00432	CcSEcCtD
Zopiclone—Cystitis noninfective—Methotrexate—esophageal cancer	0.000621	0.00426	CcSEcCtD
Zopiclone—Melaena—Methotrexate—esophageal cancer	0.000621	0.00426	CcSEcCtD
Zopiclone—Osteoarthritis—Capecitabine—esophageal cancer	0.000619	0.00425	CcSEcCtD
Zopiclone—Diplopia—Capecitabine—esophageal cancer	0.000619	0.00425	CcSEcCtD
Zopiclone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000615	0.00422	CcSEcCtD
Zopiclone—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000613	0.00421	CcSEcCtD
Zopiclone—Cystitis—Methotrexate—esophageal cancer	0.000613	0.00421	CcSEcCtD
Zopiclone—Migraine—Capecitabine—esophageal cancer	0.00061	0.00419	CcSEcCtD
Zopiclone—Vaginal infection—Methotrexate—esophageal cancer	0.0006	0.00412	CcSEcCtD
Zopiclone—Face oedema—Capecitabine—esophageal cancer	0.000598	0.00411	CcSEcCtD
Zopiclone—Irritability—Capecitabine—esophageal cancer	0.000591	0.00406	CcSEcCtD
Zopiclone—Mood swings—Capecitabine—esophageal cancer	0.000587	0.00403	CcSEcCtD
Zopiclone—Ataxia—Capecitabine—esophageal cancer	0.000582	0.004	CcSEcCtD
Zopiclone—Dehydration—Capecitabine—esophageal cancer	0.000576	0.00396	CcSEcCtD
Zopiclone—Mouth ulceration—Methotrexate—esophageal cancer	0.000574	0.00394	CcSEcCtD
Zopiclone—Bladder pain—Methotrexate—esophageal cancer	0.000574	0.00394	CcSEcCtD
Zopiclone—Gynaecomastia—Methotrexate—esophageal cancer	0.000568	0.0039	CcSEcCtD
Zopiclone—Dry skin—Capecitabine—esophageal cancer	0.000568	0.0039	CcSEcCtD
Zopiclone—Hypokalaemia—Capecitabine—esophageal cancer	0.000564	0.00387	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000558	0.00383	CcSEcCtD
Zopiclone—Gastritis—Capecitabine—esophageal cancer	0.000548	0.00376	CcSEcCtD
Zopiclone—Muscular weakness—Capecitabine—esophageal cancer	0.000546	0.00375	CcSEcCtD
Zopiclone—Tinnitus—Cisplatin—esophageal cancer	0.000542	0.00372	CcSEcCtD
Zopiclone—Lymphadenopathy—Methotrexate—esophageal cancer	0.000541	0.00371	CcSEcCtD
Zopiclone—Influenza—Capecitabine—esophageal cancer	0.000535	0.00368	CcSEcCtD
Zopiclone—Dysphagia—Capecitabine—esophageal cancer	0.000535	0.00368	CcSEcCtD
Zopiclone—Asthma—Capecitabine—esophageal cancer	0.000535	0.00368	CcSEcCtD
Zopiclone—Thrombophlebitis—Methotrexate—esophageal cancer	0.000533	0.00366	CcSEcCtD
Zopiclone—Photosensitivity—Methotrexate—esophageal cancer	0.000525	0.00361	CcSEcCtD
Zopiclone—Bronchitis—Capecitabine—esophageal cancer	0.000515	0.00354	CcSEcCtD
Zopiclone—Alopecia—Cisplatin—esophageal cancer	0.000514	0.00353	CcSEcCtD
Zopiclone—Dysuria—Capecitabine—esophageal cancer	0.000501	0.00344	CcSEcCtD
Zopiclone—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000489	0.00336	CcSEcCtD
Zopiclone—Weight increased—Capecitabine—esophageal cancer	0.000487	0.00335	CcSEcCtD
Zopiclone—Muscle spasms—Cisplatin—esophageal cancer	0.000487	0.00334	CcSEcCtD
Zopiclone—Weight decreased—Capecitabine—esophageal cancer	0.000484	0.00333	CcSEcCtD
Zopiclone—Vision blurred—Cisplatin—esophageal cancer	0.000477	0.00328	CcSEcCtD
Zopiclone—Depression—Capecitabine—esophageal cancer	0.000476	0.00327	CcSEcCtD
Zopiclone—Tremor—Cisplatin—esophageal cancer	0.000474	0.00326	CcSEcCtD
Zopiclone—Ill-defined disorder—Cisplatin—esophageal cancer	0.00047	0.00322	CcSEcCtD
Zopiclone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000468	0.00321	CcSEcCtD
Zopiclone—Anaemia—Cisplatin—esophageal cancer	0.000468	0.00321	CcSEcCtD
Zopiclone—Stomatitis—Capecitabine—esophageal cancer	0.000465	0.0032	CcSEcCtD
Zopiclone—Urinary tract infection—Capecitabine—esophageal cancer	0.000464	0.00319	CcSEcCtD
Zopiclone—Conjunctivitis—Capecitabine—esophageal cancer	0.000464	0.00319	CcSEcCtD
Zopiclone—Osteoarthritis—Methotrexate—esophageal cancer	0.000461	0.00317	CcSEcCtD
Zopiclone—Malaise—Cisplatin—esophageal cancer	0.000456	0.00313	CcSEcCtD
Zopiclone—Haematuria—Capecitabine—esophageal cancer	0.000455	0.00313	CcSEcCtD
Zopiclone—Epistaxis—Capecitabine—esophageal cancer	0.00045	0.00309	CcSEcCtD
Zopiclone—Irritability—Methotrexate—esophageal cancer	0.00044	0.00302	CcSEcCtD
Zopiclone—Convulsion—Cisplatin—esophageal cancer	0.000438	0.00301	CcSEcCtD
Zopiclone—Mood swings—Methotrexate—esophageal cancer	0.000437	0.003	CcSEcCtD
Zopiclone—Ataxia—Methotrexate—esophageal cancer	0.000434	0.00298	CcSEcCtD
Zopiclone—Myalgia—Cisplatin—esophageal cancer	0.000431	0.00296	CcSEcCtD
Zopiclone—Rhinitis—Capecitabine—esophageal cancer	0.00043	0.00295	CcSEcCtD
Zopiclone—Anxiety—Cisplatin—esophageal cancer	0.000429	0.00295	CcSEcCtD
Zopiclone—Hepatitis—Capecitabine—esophageal cancer	0.000429	0.00294	CcSEcCtD
Zopiclone—Hypoaesthesia—Capecitabine—esophageal cancer	0.000426	0.00293	CcSEcCtD
Zopiclone—Discomfort—Cisplatin—esophageal cancer	0.000426	0.00292	CcSEcCtD
Zopiclone—Pharyngitis—Capecitabine—esophageal cancer	0.000425	0.00292	CcSEcCtD
Zopiclone—Oedema peripheral—Capecitabine—esophageal cancer	0.000422	0.0029	CcSEcCtD
Zopiclone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000413	0.00284	CcSEcCtD
Zopiclone—Infection—Cisplatin—esophageal cancer	0.00041	0.00282	CcSEcCtD
Zopiclone—Erythema multiforme—Capecitabine—esophageal cancer	0.000405	0.00278	CcSEcCtD
Zopiclone—Tachycardia—Cisplatin—esophageal cancer	0.000403	0.00277	CcSEcCtD
Zopiclone—Tinnitus—Capecitabine—esophageal cancer	0.0004	0.00274	CcSEcCtD
Zopiclone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000399	0.00274	CcSEcCtD
Zopiclone—Asthma—Methotrexate—esophageal cancer	0.000399	0.00274	CcSEcCtD
Zopiclone—Anorexia—Cisplatin—esophageal cancer	0.000394	0.0027	CcSEcCtD
Zopiclone—Chills—Capecitabine—esophageal cancer	0.000385	0.00264	CcSEcCtD
Zopiclone—Alopecia—Capecitabine—esophageal cancer	0.000379	0.0026	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000376	0.00258	CcSEcCtD
Zopiclone—Dysuria—Methotrexate—esophageal cancer	0.000373	0.00256	CcSEcCtD
Zopiclone—Paraesthesia—Cisplatin—esophageal cancer	0.000371	0.00255	CcSEcCtD
Zopiclone—Dyspnoea—Cisplatin—esophageal cancer	0.000368	0.00253	CcSEcCtD
Zopiclone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000367	0.00252	CcSEcCtD
Zopiclone—Dysgeusia—Capecitabine—esophageal cancer	0.000365	0.00251	CcSEcCtD
Zopiclone—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000364	0.0025	CcSEcCtD
Zopiclone—Back pain—Capecitabine—esophageal cancer	0.000361	0.00248	CcSEcCtD
Zopiclone—Decreased appetite—Cisplatin—esophageal cancer	0.000359	0.00247	CcSEcCtD
Zopiclone—Muscle spasms—Capecitabine—esophageal cancer	0.000359	0.00246	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000357	0.00245	CcSEcCtD
Zopiclone—Drowsiness—Methotrexate—esophageal cancer	0.000355	0.00244	CcSEcCtD
Zopiclone—Depression—Methotrexate—esophageal cancer	0.000354	0.00243	CcSEcCtD
Zopiclone—Pain—Cisplatin—esophageal cancer	0.000353	0.00243	CcSEcCtD
Zopiclone—Vision blurred—Capecitabine—esophageal cancer	0.000352	0.00241	CcSEcCtD
Zopiclone—Tremor—Capecitabine—esophageal cancer	0.00035	0.0024	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—esophageal cancer	0.000346	0.00238	CcSEcCtD
Zopiclone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000346	0.00238	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—esophageal cancer	0.000345	0.00237	CcSEcCtD
Zopiclone—Anaemia—Capecitabine—esophageal cancer	0.000345	0.00237	CcSEcCtD
Zopiclone—Sweating—Methotrexate—esophageal cancer	0.000341	0.00234	CcSEcCtD
Zopiclone—Feeling abnormal—Cisplatin—esophageal cancer	0.00034	0.00234	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—esophageal cancer	0.000339	0.00233	CcSEcCtD
Zopiclone—Malaise—Capecitabine—esophageal cancer	0.000336	0.00231	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—esophageal cancer	0.000335	0.0023	CcSEcCtD
Zopiclone—Vertigo—Capecitabine—esophageal cancer	0.000335	0.0023	CcSEcCtD
Zopiclone—Palpitations—Capecitabine—esophageal cancer	0.00033	0.00226	CcSEcCtD
Zopiclone—Body temperature increased—Cisplatin—esophageal cancer	0.000327	0.00224	CcSEcCtD
Zopiclone—Hypertension—Capecitabine—esophageal cancer	0.000322	0.00221	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—esophageal cancer	0.000319	0.00219	CcSEcCtD
Zopiclone—Myalgia—Capecitabine—esophageal cancer	0.000318	0.00218	CcSEcCtD
Zopiclone—Chest pain—Capecitabine—esophageal cancer	0.000318	0.00218	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—esophageal cancer	0.000317	0.00217	CcSEcCtD
Zopiclone—Anxiety—Capecitabine—esophageal cancer	0.000317	0.00217	CcSEcCtD
Zopiclone—Discomfort—Capecitabine—esophageal cancer	0.000314	0.00216	CcSEcCtD
Zopiclone—Dry mouth—Capecitabine—esophageal cancer	0.000311	0.00213	CcSEcCtD
Zopiclone—Confusional state—Capecitabine—esophageal cancer	0.000307	0.00211	CcSEcCtD
Zopiclone—Hypersensitivity—Cisplatin—esophageal cancer	0.000304	0.00209	CcSEcCtD
Zopiclone—Infection—Capecitabine—esophageal cancer	0.000302	0.00208	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—esophageal cancer	0.000302	0.00207	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—esophageal cancer	0.000297	0.00204	CcSEcCtD
Zopiclone—Tachycardia—Capecitabine—esophageal cancer	0.000297	0.00204	CcSEcCtD
Zopiclone—Asthenia—Cisplatin—esophageal cancer	0.000296	0.00204	CcSEcCtD
Zopiclone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000294	0.00202	CcSEcCtD
Zopiclone—Anorexia—Capecitabine—esophageal cancer	0.00029	0.00199	CcSEcCtD
Zopiclone—Chills—Methotrexate—esophageal cancer	0.000286	0.00197	CcSEcCtD
Zopiclone—Diarrhoea—Cisplatin—esophageal cancer	0.000283	0.00194	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—esophageal cancer	0.000282	0.00194	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000277	0.0019	CcSEcCtD
Zopiclone—Insomnia—Capecitabine—esophageal cancer	0.000275	0.00189	CcSEcCtD
Zopiclone—Paraesthesia—Capecitabine—esophageal cancer	0.000273	0.00188	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—esophageal cancer	0.000272	0.00187	CcSEcCtD
Zopiclone—Dyspnoea—Capecitabine—esophageal cancer	0.000271	0.00186	CcSEcCtD
Zopiclone—Back pain—Methotrexate—esophageal cancer	0.000269	0.00184	CcSEcCtD
Zopiclone—Dyspepsia—Capecitabine—esophageal cancer	0.000268	0.00184	CcSEcCtD
Zopiclone—Decreased appetite—Capecitabine—esophageal cancer	0.000265	0.00182	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000263	0.00181	CcSEcCtD
Zopiclone—Vomiting—Cisplatin—esophageal cancer	0.000263	0.0018	CcSEcCtD
Zopiclone—Fatigue—Capecitabine—esophageal cancer	0.000263	0.0018	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—esophageal cancer	0.000262	0.0018	CcSEcCtD
Zopiclone—Rash—Cisplatin—esophageal cancer	0.00026	0.00179	CcSEcCtD
Zopiclone—Pain—Capecitabine—esophageal cancer	0.00026	0.00179	CcSEcCtD
Zopiclone—Constipation—Capecitabine—esophageal cancer	0.00026	0.00179	CcSEcCtD
Zopiclone—Dermatitis—Cisplatin—esophageal cancer	0.00026	0.00179	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000258	0.00177	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—esophageal cancer	0.000257	0.00176	CcSEcCtD
Zopiclone—Feeling abnormal—Capecitabine—esophageal cancer	0.000251	0.00172	CcSEcCtD
Zopiclone—Malaise—Methotrexate—esophageal cancer	0.00025	0.00172	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—esophageal cancer	0.00025	0.00171	CcSEcCtD
Zopiclone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000249	0.00171	CcSEcCtD
Zopiclone—Nausea—Cisplatin—esophageal cancer	0.000245	0.00168	CcSEcCtD
Zopiclone—Urticaria—Capecitabine—esophageal cancer	0.000242	0.00166	CcSEcCtD
Zopiclone—Abdominal pain—Capecitabine—esophageal cancer	0.000241	0.00165	CcSEcCtD
Zopiclone—Body temperature increased—Capecitabine—esophageal cancer	0.000241	0.00165	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—esophageal cancer	0.000241	0.00165	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—esophageal cancer	0.000236	0.00162	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—esophageal cancer	0.000236	0.00162	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—esophageal cancer	0.000234	0.0016	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—esophageal cancer	0.000229	0.00157	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000227	0.00156	CcSEcCtD
Zopiclone—Infection—Methotrexate—esophageal cancer	0.000225	0.00155	CcSEcCtD
Zopiclone—Hypersensitivity—Capecitabine—esophageal cancer	0.000224	0.00154	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000219	0.0015	CcSEcCtD
Zopiclone—Asthenia—Capecitabine—esophageal cancer	0.000218	0.0015	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—esophageal cancer	0.000216	0.00148	CcSEcCtD
Zopiclone—Pruritus—Capecitabine—esophageal cancer	0.000215	0.00148	CcSEcCtD
Zopiclone—Diarrhoea—Capecitabine—esophageal cancer	0.000208	0.00143	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000207	0.00142	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—esophageal cancer	0.000205	0.00141	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—esophageal cancer	0.000204	0.0014	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—esophageal cancer	0.000202	0.00139	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—esophageal cancer	0.000201	0.00138	CcSEcCtD
Zopiclone—Dizziness—Capecitabine—esophageal cancer	0.000201	0.00138	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—esophageal cancer	0.0002	0.00137	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—esophageal cancer	0.000197	0.00135	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000196	0.00134	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—esophageal cancer	0.000195	0.00134	CcSEcCtD
Zopiclone—Pain—Methotrexate—esophageal cancer	0.000194	0.00133	CcSEcCtD
Zopiclone—Vomiting—Capecitabine—esophageal cancer	0.000194	0.00133	CcSEcCtD
Zopiclone—Rash—Capecitabine—esophageal cancer	0.000192	0.00132	CcSEcCtD
Zopiclone—Dermatitis—Capecitabine—esophageal cancer	0.000192	0.00132	CcSEcCtD
Zopiclone—Headache—Capecitabine—esophageal cancer	0.000191	0.00131	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—esophageal cancer	0.000187	0.00128	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000185	0.00127	CcSEcCtD
Zopiclone—Nausea—Capecitabine—esophageal cancer	0.000181	0.00124	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—esophageal cancer	0.00018	0.00124	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—esophageal cancer	0.000179	0.00123	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—esophageal cancer	0.000179	0.00123	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—esophageal cancer	0.000167	0.00115	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—esophageal cancer	0.000163	0.00112	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—esophageal cancer	0.00016	0.0011	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—esophageal cancer	0.000155	0.00106	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—esophageal cancer	0.00015	0.00103	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—esophageal cancer	0.000144	0.00099	CcSEcCtD
Zopiclone—Rash—Methotrexate—esophageal cancer	0.000143	0.000981	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—esophageal cancer	0.000143	0.000981	CcSEcCtD
Zopiclone—Headache—Methotrexate—esophageal cancer	0.000142	0.000975	CcSEcCtD
Zopiclone—Nausea—Methotrexate—esophageal cancer	0.000135	0.000925	CcSEcCtD
Zopiclone—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000106	0.000827	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000105	0.000821	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000105	0.000816	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000103	0.000807	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000103	0.000806	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000102	0.000798	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000102	0.000797	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000102	0.000796	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000102	0.000794	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP1B1—esophageal cancer	0.000101	0.000789	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	9.98e-05	0.000779	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	9.97e-05	0.000778	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.96e-05	0.000777	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	9.76e-05	0.000761	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	9.69e-05	0.000756	CbGpPWpGaD
Zopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	9.61e-05	0.00075	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	9.52e-05	0.000742	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	9.46e-05	0.000738	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	9.38e-05	0.000732	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	9.33e-05	0.000728	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.04e-05	0.000705	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.91e-05	0.000695	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	8.79e-05	0.000686	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	8.67e-05	0.000676	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	8.24e-05	0.000642	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.18e-05	0.000638	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	8.12e-05	0.000634	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	7.94e-05	0.00062	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—BLVRB—esophageal cancer	7.92e-05	0.000617	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC52A3—esophageal cancer	7.92e-05	0.000617	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.85e-05	0.000613	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	7.74e-05	0.000604	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	7.64e-05	0.000596	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.17e-05	0.000559	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	7.12e-05	0.000556	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.89e-05	0.000537	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.82e-05	0.000532	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.74e-05	0.000526	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC10A2—esophageal cancer	6.73e-05	0.000525	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CA1—esophageal cancer	6.73e-05	0.000525	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.69e-05	0.000522	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.61e-05	0.000516	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.59e-05	0.000514	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.57e-05	0.000513	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.46e-05	0.000504	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.42e-05	0.000501	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.42e-05	0.0005	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.39e-05	0.000498	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.31e-05	0.000492	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.3e-05	0.000491	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.2e-05	0.000483	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.16e-05	0.00048	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CA2—esophageal cancer	6.16e-05	0.00048	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.05e-05	0.000472	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.02e-05	0.000469	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—BLVRB—esophageal cancer	5.92e-05	0.000461	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC52A3—esophageal cancer	5.92e-05	0.000461	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.75e-05	0.000449	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ADH7—esophageal cancer	5.72e-05	0.000446	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PLCE1—esophageal cancer	5.72e-05	0.000446	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.66e-05	0.000441	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.51e-05	0.00043	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.43e-05	0.000424	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.37e-05	0.000419	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.36e-05	0.000418	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.29e-05	0.000412	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.25e-05	0.000409	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—BLVRB—esophageal cancer	5.11e-05	0.000399	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC52A3—esophageal cancer	5.11e-05	0.000399	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.11e-05	0.000398	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.04e-05	0.000393	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC10A2—esophageal cancer	5.03e-05	0.000392	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CA1—esophageal cancer	5.03e-05	0.000392	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ADH1B—esophageal cancer	5.02e-05	0.000391	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TYMP—esophageal cancer	4.8e-05	0.000374	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.68e-05	0.000365	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP26A1—esophageal cancer	4.67e-05	0.000364	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CA2—esophageal cancer	4.6e-05	0.000359	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.57e-05	0.000356	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALOX15—esophageal cancer	4.55e-05	0.000355	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.42e-05	0.000345	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CA1—esophageal cancer	4.35e-05	0.000339	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC10A2—esophageal cancer	4.35e-05	0.000339	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—TPI1—esophageal cancer	4.34e-05	0.000338	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTO1—esophageal cancer	4.34e-05	0.000338	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.29e-05	0.000335	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ADH7—esophageal cancer	4.28e-05	0.000334	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PLCE1—esophageal cancer	4.28e-05	0.000334	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.22e-05	0.000329	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—BLVRB—esophageal cancer	4.16e-05	0.000325	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC52A3—esophageal cancer	4.16e-05	0.000325	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALDOB—esophageal cancer	4.16e-05	0.000324	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.14e-05	0.000323	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.12e-05	0.000321	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.04e-05	0.000315	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GAPDH—esophageal cancer	4e-05	0.000312	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CA2—esophageal cancer	3.98e-05	0.00031	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CRABP1—esophageal cancer	3.97e-05	0.000309	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.89e-05	0.000303	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GNG7—esophageal cancer	3.77e-05	0.000294	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ADH1B—esophageal cancer	3.75e-05	0.000292	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.72e-05	0.00029	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PLCE1—esophageal cancer	3.7e-05	0.000288	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ADH7—esophageal cancer	3.7e-05	0.000288	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.65e-05	0.000285	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TYMP—esophageal cancer	3.58e-05	0.00028	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CA1—esophageal cancer	3.54e-05	0.000276	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.54e-05	0.000276	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALDH2—esophageal cancer	3.54e-05	0.000276	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.53e-05	0.000276	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP26A1—esophageal cancer	3.49e-05	0.000272	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALOX15—esophageal cancer	3.4e-05	0.000265	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTT1—esophageal cancer	3.36e-05	0.000262	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.32e-05	0.000259	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.31e-05	0.000258	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.24e-05	0.000253	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTO1—esophageal cancer	3.24e-05	0.000253	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TPI1—esophageal cancer	3.24e-05	0.000253	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CA2—esophageal cancer	3.24e-05	0.000252	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.16e-05	0.000247	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ENO1—esophageal cancer	3.15e-05	0.000246	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALDOB—esophageal cancer	3.11e-05	0.000242	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSME2—esophageal cancer	3.11e-05	0.000242	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSME1—esophageal cancer	3.11e-05	0.000242	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TYMP—esophageal cancer	3.1e-05	0.000242	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.01e-05	0.000235	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.01e-05	0.000235	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ADH7—esophageal cancer	3.01e-05	0.000235	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.99e-05	0.000233	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.97e-05	0.000232	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.96e-05	0.000231	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.94e-05	0.000229	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GNG7—esophageal cancer	2.82e-05	0.00022	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.8e-05	0.000219	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TPI1—esophageal cancer	2.8e-05	0.000219	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.74e-05	0.000214	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.74e-05	0.000214	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.71e-05	0.000212	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.69e-05	0.000209	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.68e-05	0.000209	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.64e-05	0.000206	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.64e-05	0.000206	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.59e-05	0.000202	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.56e-05	0.0002	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TYMP—esophageal cancer	2.52e-05	0.000197	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.52e-05	0.000196	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.51e-05	0.000196	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.48e-05	0.000194	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.45e-05	0.000191	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GNG7—esophageal cancer	2.44e-05	0.00019	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.39e-05	0.000186	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.35e-05	0.000184	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ENO1—esophageal cancer	2.35e-05	0.000184	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CA1—esophageal cancer	2.33e-05	0.000182	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.33e-05	0.000182	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSME2—esophageal cancer	2.32e-05	0.000181	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSME1—esophageal cancer	2.32e-05	0.000181	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—HMOX1—esophageal cancer	2.3e-05	0.000179	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.28e-05	0.000178	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.28e-05	0.000178	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TPI1—esophageal cancer	2.28e-05	0.000178	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.26e-05	0.000176	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ABCB1—esophageal cancer	2.21e-05	0.000172	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.19e-05	0.000171	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.17e-05	0.000169	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.15e-05	0.000167	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.14e-05	0.000167	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CA2—esophageal cancer	2.13e-05	0.000166	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.1e-05	0.000164	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.09e-05	0.000163	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ENO1—esophageal cancer	2.04e-05	0.000159	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.04e-05	0.000159	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSME1—esophageal cancer	2.01e-05	0.000156	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSME2—esophageal cancer	2.01e-05	0.000156	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1B1—esophageal cancer	2e-05	0.000156	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ADH7—esophageal cancer	1.98e-05	0.000155	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.98e-05	0.000155	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GNG7—esophageal cancer	1.98e-05	0.000155	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.88e-05	0.000147	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.86e-05	0.000145	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.77e-05	0.000138	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.75e-05	0.000137	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.75e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.74e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.74e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.73e-05	0.000135	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.72e-05	0.000134	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.67e-05	0.00013	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TYMP—esophageal cancer	1.66e-05	0.00013	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.66e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ENO1—esophageal cancer	1.66e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.65e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSME2—esophageal cancer	1.63e-05	0.000127	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSME1—esophageal cancer	1.63e-05	0.000127	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.63e-05	0.000127	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.62e-05	0.000126	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.58e-05	0.000123	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.5e-05	0.000117	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.5e-05	0.000117	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.48e-05	0.000116	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CREBBP—esophageal cancer	1.47e-05	0.000115	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.46e-05	0.000114	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.44e-05	0.000112	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.43e-05	0.000111	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.43e-05	0.000111	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.41e-05	0.00011	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.39e-05	0.000108	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.38e-05	0.000107	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.32e-05	0.000103	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NOS3—esophageal cancer	1.32e-05	0.000103	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.31e-05	0.000102	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.23e-05	9.56e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.21e-05	9.43e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—esophageal cancer	1.21e-05	9.42e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.19e-05	9.25e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.17e-05	9.09e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.16e-05	9.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.15e-05	8.99e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.1e-05	8.6e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.09e-05	8.52e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.09e-05	8.52e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.08e-05	8.41e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.08e-05	8.4e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.08e-05	8.4e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—EP300—esophageal cancer	1e-05	7.83e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NOS3—esophageal cancer	9.87e-06	7.7e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CREBBP—esophageal cancer	9.53e-06	7.43e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.29e-06	7.25e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—esophageal cancer	9.02e-06	7.04e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.77e-06	6.84e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.73e-06	6.81e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NOS3—esophageal cancer	8.53e-06	6.65e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.97e-06	6.22e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—esophageal cancer	7.8e-06	6.08e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.75e-06	6.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.65e-06	5.97e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—EP300—esophageal cancer	7.51e-06	5.85e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.43e-06	5.8e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NOS3—esophageal cancer	6.94e-06	5.41e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—EP300—esophageal cancer	6.49e-06	5.06e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.35e-06	4.95e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.55e-06	4.33e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—EP300—esophageal cancer	5.28e-06	4.12e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.11e-06	3.99e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.8e-06	3.74e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NOS3—esophageal cancer	4.58e-06	3.57e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.19e-06	3.27e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.91e-06	3.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—EP300—esophageal cancer	3.48e-06	2.72e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.58e-06	2.01e-05	CbGpPWpGaD
